Prothena Corporation plc (PRTA)
NASDAQ: PRTA · IEX Real-Time Price · USD
23.58
-0.03 (-0.13%)
At close: Jul 19, 2024, 4:00 PM
23.50
-0.08 (-0.34%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Prothena Corporation Revenue

Prothena Corporation had revenue of $89.25M in the twelve months ending March 31, 2024, with 62.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $50.00K. In the year 2023, Prothena Corporation had annual revenue of $91.37M with 69.50% growth.

Revenue (ttm)
$89.25M
Revenue Growth
+62.51%
P/S Ratio
14.21
Revenue / Employee
$515,902
Employees
173
Market Cap
1.27B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202391.37M37.47M69.50%
Dec 31, 202253.91M-146.67M-73.13%
Dec 31, 2021200.58M199.72M23,414.30%
Dec 31, 2020853.00K39.00K4.79%
Dec 31, 2019814.00K-141.00K-14.76%
Dec 31, 2018955.00K-26.56M-96.53%
Dec 31, 201727.52M26.46M2,508.44%
Dec 31, 20161.06M-552.00K-34.35%
Dec 31, 20151.61M-49.25M-96.84%
Dec 31, 201450.85M50.18M7,422.78%
Dec 31, 2013676.00K-1.98M-74.57%
Dec 31, 20122.66M2.15M424.26%
Dec 31, 2011507.00K-736.00K-59.21%
Dec 31, 20101.24M--
Dec 31, 20090--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Omnicell 1.10B
AtriCure 414.60M
Arcus Biosciences 237.00M
Xencor 162.18M
Ardelyx 159.11M
Establishment Labs Holdings 155.79M
Gyre Therapeutics 140.62M
Immatics 80.95M
Revenue Rankings